PRV UL13 inhibits cGAS–STING-mediated IFN-β production by phosphorylating IRF3
Open Access
- 15 September 2020
- journal article
- research article
- Published by Springer Nature in Veterinary Research
- Vol. 51 (1) , 1-16
Abstract
Cyclic GMP-AMP (cGAMP) synthase (cGAS) is an intracellular sensor of cytoplasmic viral DNA created during virus infection, which subsequently activates the stimulator of interferon gene (STING)-dependent type I interferon response to eliminate pathogens. In contrast, viruses have developed different strategies to modulate this signalling pathway. Pseudorabies virus (PRV), an alphaherpesvirus, is the causative agent of Aujeszky’s disease (AD), a notable disease that causes substantial economic loss to the swine industry globally. Previous reports have shown that PRV infection induces cGAS-dependent IFN-β production, conversely hydrolysing cGAMP, a second messenger synthesized by cGAS, and attenuates PRV-induced IRF3 activation and IFN-β secretion. However, it is not clear whether PRV open reading frames (ORFs) modulate the cGAS–STING-IRF3 pathway. Here, 50 PRV ORFs were screened, showing that PRV UL13 serine/threonine kinase blocks the cGAS–STING-IRF3-, poly(I:C)- or VSV-mediated transcriptional activation of the IFN-β gene. Importantly, it was discovered that UL13 phosphorylates IRF3, and its kinase activity is indispensable for such an inhibitory effect. Moreover, UL13 does not affect IRF3 dimerization, nuclear translocation or association with CREB-binding protein (CBP) but attenuates the binding of IRF3 to the IRF3-responsive promoter. Consistent with this, it was discovered that UL13 inhibits the expression of multiple interferon-stimulated genes (ISGs) induced by cGAS–STING or poly(I:C). Finally, it was determined that PRV infection can activate IRF3 by recruiting it to the nucleus, and PRVΔUL13 mutants enhance the transactivation level of the IFN-β gene. Taken together, the data from the present study demonstrated that PRV UL13 inhibits cGAS–STING-mediated IFN-β production by phosphorylating IRF3.Keywords
Funding Information
- National Key Research and Development Program of China (2017YFD0502306-1)
- National Natural Science Foundation (31472218)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Fundamental Research Funds for the Central Universities (Y0201700559)
This publication has 55 references indexed in Scilit:
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- Viral Serine/Threonine Protein KinasesJournal of Virology, 2011
- Varicella-Zoster Virus Immediate-Early Protein 62 Blocks Interferon Regulatory Factor 3 (IRF3) Phosphorylation at Key Serine Residues: a Novel Mechanism of IRF3 Inhibition among HerpesvirusesJournal of Virology, 2010
- Epstein-Barr Virus BGLF4 Kinase Suppresses the Interferon Regulatory Factor 3 Signaling PathwayJournal of Virology, 2009
- Conserved Herpesviral Kinase Promotes Viral Persistence by Inhibiting the IRF-3-Mediated Type I Interferon ResponseCell Host & Microbe, 2009
- TRIM family proteins and their emerging roles in innate immunityNature Reviews Immunology, 2008
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008
- Substrate specificity of the herpes simplex virus type 2 UL13 protein kinaseVirology, 2008
- Pseudorabies Virus EP0 Protein Counteracts an Interferon-Induced Antiviral State in a Species-Specific MannerJournal of Virology, 2006
- Suppression of the Interferon-Mediated Innate Immune Response by Pseudorabies VirusJournal of Virology, 2006